{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:36:13Z","timestamp":1763037373434,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Veterans Affairs Western New York Healthcare System"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.avsg.2019.08.093","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:56:23Z","timestamp":1571169383000},"page":"275-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI\/ARB) are Associated with Improved Limb Salvage after Infrapopliteal Interventions for Critical Limb Ischemia"],"prefix":"10.1016","volume":"63","author":[{"given":"Sikandar Z.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Montross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Cherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej L.","family":"Dryjski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan H.","family":"Dosluoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2019.08.093_bib1","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2019.08.093_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","article-title":"Critical limb ischemia","volume":"51","author":"Varu","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-societyconsensus for the management of peripheral arterial disease(TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib4","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib5","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2019.08.093_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diabres.2013.12.060","article-title":"Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study","volume":"103","author":"Faglia","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.avsg.2019.08.093_bib7","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease","volume":"47","author":"Feringa","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.08.093_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2019.08.093_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1358863X15574321","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia","volume":"20","author":"Armstrong","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2019.08.093_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jvs.2017.07.130","article-title":"Long-term mortality benefit of renin-angiotensin system inhibitors in patients with chronic limb-threatening ischemia undergoing vascular intervention","volume":"67","author":"Bodewes","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/bjs.9198","article-title":"Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication","volume":"100","author":"Shahin","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib12","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1177\/1060028013501803","article-title":"Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease","volume":"47","author":"Hunter","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.avsg.2019.08.093_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2013.09.037","article-title":"Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication","volume":"231","author":"Shahin","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2019.08.093_bib14","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jvs.2015.11.052","article-title":"Poorer limb salvage in African American men with chronic limb ischemia is due to advanced clinical stage and higher anatomic complexity at presentation","volume":"63","author":"Rivero","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jvs.2008.06.006","article-title":"Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease","volume":"48","author":"Dosluoglu","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(87)92441-X","article-title":"Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication","volume":"2","author":"Roberts","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2019.08.093_bib19","first-page":"22","article-title":"The effect of enalapril on leg muscle blood flow in patients with claudication","volume":"9","author":"Sonecha","year":"1990","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2019.08.093_bib20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/000331978803901103","article-title":"Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound","volume":"39","author":"Bernardi","year":"1988","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2019.08.093_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2011.02.044","article-title":"Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials","volume":"216","author":"Shahin","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2019.08.093_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11886-012-0275-9","article-title":"Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention","volume":"14","author":"Patarroyo Aponte","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.avsg.2019.08.093_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2011.12.005","article-title":"Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials","volume":"221","author":"Shahin","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2019.08.093_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/HJH.0b013e3282f8e3b6","article-title":"Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients","volume":"26","author":"Ahimastos","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.avsg.2019.08.093_bib25","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2337\/diacare.24.12.2107","article-title":"Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients","volume":"24","author":"Suzuki","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2019.08.093_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jvs.2015.09.033","article-title":"Increased preoperative pulse pressure predicts procedural complications and mortality in patients who undergo tibial interventions for critical limb ischemia","volume":"63","author":"Zettervall","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.08.093_bib27","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jacc.2007.12.058","article-title":"Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease","volume":"51","author":"Guzman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.08.093_bib28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9149(02)02242-7","article-title":"Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting","volume":"89","author":"Ellis","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.avsg.2019.08.093_bib29","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/MJT.0b013e3182979b59","article-title":"The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in postangioplasty restenosis","volume":"22","author":"Liu","year":"2015","journal-title":"Am J Ther"},{"key":"10.1016\/j.avsg.2019.08.093_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0735-1097(94)00368-Z","volume":"25","author":"Faxon","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.08.093_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.86.1.100","volume":"86","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2019.08.093_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.89.1.385","article-title":"Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty","volume":"89","author":"Desmet","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2019.08.093_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1253\/circj.66.311","article-title":"Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele","volume":"66","author":"Okumura","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.avsg.2019.08.093_bib34","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.0000223145.74217.e7","article-title":"ACE polymorphisms","volume":"98","author":"Sayed-Tabatabaei","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2019.08.093_bib35","first-page":"E245","article-title":"Explaining the discrepancy between lower patency and higher limb salvage rates after revascularization for critical limb ischemia","volume":"13","author":"Richards","year":"2016","journal-title":"Vasc Dis Manag"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509619307812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509619307812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:57:17Z","timestamp":1760187437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509619307812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":35,"alternative-id":["S0890509619307812"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2019.08.093","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI\/ARB) are Associated with Improved Limb Salvage after Infrapopliteal Interventions for Critical Limb Ischemia","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2019.08.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}